4DM-60172-60281
3 vaccinations
2 coded responses
40 check-ins
2 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 787 / TX
- Registered
- 2021-04-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Registered dependents
P6H-15317-54573
Child or adolescent in my care · Male · 2022-07-28
Timeline
-
2021-04-01
Registered in v-safe
-
2021-04-01
Dose 1 — Pfizer-BioNTech
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-15
-
2021-04-22
Dose 2 — Pfizer-BioNTech
- 2021-04-22
- 2021-04-23
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
-
2021-05-06
Survey response — day 14, dose 2MedDRA: Office visit, Pregnancy, Urinary tract infection — Feeling: Good · Get care from a doctor or other healthcare professionalFree text: Symptoms: I had a scheduled 20 week pregnancy check up on 5/3 and urine sample came back positive for a urinary tract infection. Was prescribed antibiotics. · Healthcare visit (other): Visit to my OBs office.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-06
Report sent to call center — day 14, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-13
- 2021-05-20
- 2021-05-29
- 2021-06-03
- 2021-06-07
- 2021-07-23
-
2021-10-21
Survey response — 6 months, dose 2MedDRA: Caesarean section — Feeling: Good · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Had baby- Caesarean section Postpartum · Healthcare visit (other): Delivered baby at 38 weeks via c-sectionMedDRA releases: 2024-11 · check-in free text available
-
2021-10-21
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2021-10-22
Call successfulOther
-
2021-10-27
Dose 3 — Pfizer-BioNTech
- 2021-10-27
-
2021-10-28
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-10-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling · Fatigue or tirednessAdult check-in
- 2021-10-30
- 2021-10-31
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2022-01-27
- 2022-04-27
- 2022-10-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-01 | Pfizer-BioNTech | |
| 2 | 2021-04-22 | Pfizer-BioNTech | |
| 3 | 2021-10-27 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-06 | Successful | Other |
| 2021-10-21 | Successful 2021-10-22 |
Other |
Free text
Release 8 — day 14, dose 2
Symptoms: I had a scheduled 20 week pregnancy check up on 5/3 and urine sample came back positive for a urinary tract infection. Was prescribed antibiotics.
Healthcare visit (other): Visit to my OBs office.
Release 10 — 6 months, dose 2
Symptoms: Had baby- Caesarean section Postpartum
Healthcare visit (other): Delivered baby at 38 weeks via c-section
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Caesarean section | · | · | ✓ |
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Caesarean section | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Urinary tract infection | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release